Final answer:
The priority assessment for a patient in chronic renal failure taking hydrochlorothiazide (HCTZ) is reviewing lab work for hypokalemia and hyponatremia.
Step-by-step explanation:
The nurse should prioritize reviewing the lab work for hypokalemia and hyponatremia for the patient in chronic renal failure who is taking hydrochlorothiazide (HCTZ). HCTZ is a diuretic medication that works on the distal convoluted tubule, increasing the excretion of sodium and water. However, one of the side effects of HCTZ is the loss of potassium and sodium, which can lead to hypokalemia (low potassium levels) and hyponatremia (low sodium levels).
Monitoring lab values is essential to assess the patient's electrolyte balance and ensure an adequate response to the medication. Hypokalemia can cause muscle weakness, irregular heartbeat, and fatigue, while hyponatremia can lead to confusion, seizures, and fluid imbalances.